Meletios Therapeutics
French tech company | Builders Republic
About
Biotech developing next-generation antiviral drug candidates — applying a proprietary platform to identify and optimize molecules targeting viral replication mechanisms, with a pipeline focused on hard-to-treat infectious diseases.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Venture Round
- Founded
- 2020
- City
- PARIS
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 2.8 M€ raised since 2020
Funding rounds
- Venture Round — 2021